eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0948265|metabolic syndrome |
| Sentences | 102 |
| PubMedID- 22209679 | Background & aims: non-alcoholic fatty liver disease (nafld) is commonly associated with obesity, metabolic syndrome and type 2 diabetes. |
| PubMedID- 24268461 | non-alcoholic fatty liver disease (nafld) is frequently associated with metabolic syndrome (ms) and may represent a cardiovascular (cv) risk factor. |
| PubMedID- 21040936 | The metabolic syndrome is associated with nonalcoholic fatty liver disease (nafld) as well as with insulin resistance, inflammatory adipokines, endothelial dysfunction, and higher plasma levels of nonesterified fatty acids (nefa), all of which may also affect the development of nafld. |
| PubMedID- 26399788 | nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver. |
| PubMedID- 25960770 | A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 25911912 | The aim of the study was to evaluate the main features of the gastrointestinal myoelectrical activity (gi mea) in patients with nonalcoholic fatty liver disease (nafld) associated with metabolic syndrome (ms). |
| PubMedID- 23113121 | Results: the prevalence of metabolic syndrome in nafld group was obviously higher than in controls group (47.3% vs 3.6%, p<0.001). |
| PubMedID- 21330637 | Nonalcoholic fatty liver disease (nafld) occurs in patients with components of metabolic syndrome. |
| PubMedID- 20805262 | Controlling for obesity, there is a strong association of nafld with metabolic syndrome factors (57), the development of diabetes (58), coronary artery disease mortality (59), and death from malignancy. |
| PubMedID- 21789263 | The incidence of hepatocellular carcinoma (hcc) has risen as a result of increased global burden of chronic liver disease due to hepatitis b and c virus infections, aflatoxin b1, alcoholism, and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis associated with the metabolic syndrome. |
| PubMedID- 22884916 | Background: nonalcoholic fatty liver disease is closely associated with metabolic syndrome and cardiovascular disease (cvd). |
| PubMedID- 24761121 | [24] the activity of ggt was an indicator of hepatic damage and used as sensitive marker in the diagnosis of hepatic diseases and as a marker of nafld in patients with metabolic syndrome. |
| PubMedID- 24349058 | nafld is clearly associated with features of metabolic syndrome including obesity, type 2 diabetes, hypertension, and dyslipidemia. |
| PubMedID- 20459722 | nafld is associated with obesity, the metabolic syndrome, dyslipidemia, insulin resistance, and type 2 diabetes [1]. |
| PubMedID- 22999011 | Results: nafld participants with metabolic syndrome were more likely to be non-hispanic white, older, and have higher aminotransferase levels. |
| PubMedID- 24039859 | Nonalcoholic fatty liver disease (nafld) is commonly associated with obesity, the metabolic syndrome and type ii diabetes mellitus and thus its significance parallels that of the epidemic rise of these diseases in this country and much of the world [1]. |
| PubMedID- 21387764 | [non-alcoholic fatty liver disease (nafld) in patients with metabolic syndrome and type 2 diabetes mellitus. |
| PubMedID- 26460614 | nafld is usually associated with metabolic syndromes (mets), such as type 2 diabetes, insulin resistance, hypertension, and dyslipidemia, that are accompanied by abdominal obesity [10–11]. |
| PubMedID- 20733515 | The transplant outcomes of nafld patients with metabolic syndrome comorbidities remain unclear. |
| PubMedID- 26078958 | Molecular mechanisms of nafld in metabolic syndrome. |
| PubMedID- 23419204 | Objective: while nonalcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, it is not known if nafld plays an independent role in the atherogenic dyslipidemia phenotype. |
| PubMedID- 25947379 | non-alcoholic fatty liver disease is associated with metabolic syndrome and is becoming one of the most common forms of liver disease worldwide. |
| PubMedID- 23066331 | Fatty liver, including non-alcoholic fatty liver disease, is closely associated with metabolic syndrome (ms). |
| PubMedID- 23032980 | Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults. |
| PubMedID- 22194737 | Given the high proportion of nafld patients with metabolic syndrome and the association between metabolic syndrome and type 2 diabetes mellitus (t2dm) and cardiovascular diseases [1, 41], our results suggest that a low dose of metformin might be proposed to nafld patients, especially if they meet the diagnostic criteria of metabolic syndrome [35]. |
| PubMedID- 24133664 | It is well known that obesity and metabolic syndrome are associated with nafld.5,11,12 thus higher prevalence of nafld in gyeonggi-do is associated with higher prevalence of obesity and metabolic syndrome. |
| PubMedID- 24665369 | [20] found that serum zag concentrations were the only independent predictor of the number of metabolic syndrome components in patients with nonalcoholic fatty liver disease (nafld) after stepwise linear regression analysis. |
| PubMedID- 24713801 | Background: although non-alcoholic fatty liver disease (nafld) is associated with obesity and metabolic syndrome (ms), it may also be present in lean individuals. |
| PubMedID- 26089873 | nafld, which is associated with obesity and metabolic syndrome, is an increasing concern worldwide and especially in the united states. |
| PubMedID- 24367371 | Restricting these bacteria requires il-18 and failure promotes ccl5-dependent colonic inflammation and increased tlr4 and tlr9 agonist influx into the portal vein, which eventually causes non-alcoholic fatty liver disease (nafld), a comorbidity associated with obesity, metabolic syndrome, and nash progression (144, 230). |
| PubMedID- 25988570 | Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 23286927 | Since nafld is intricately associated with the metabolic syndrome and insulin resistance, increased risk of cardiovascular disease and mortality become a real concern. |
| PubMedID- 23962027 | High ggt may be a marker of non-alcoholic fatty liver disease, which is associated with the metabolic syndrome. |
| PubMedID- 25789501 | Nonalcoholic fatty liver disease (nafld) is commonly associated with metabolic syndrome and can progress to nonalcoholic steatohepatitis (nash), which in turn leads to liver cirrhosis and hcc development [31,32]. |
| PubMedID- 25661453 | We aimed to determine the association between the quantity of liver fat and the presence of the metabolic syndrome in patients with biopsy-proven nonalcoholic fatty liver disease (nafld), independent of nonalcoholic steatohepatitis (nash). |
| PubMedID- 24834224 | The mean body mass index of the 22 cases was 31.18 +/-5.7 and non-alcoholic fatty liver disease was associated with the metabolic syndrome in these subjects. |
| PubMedID- 20645852 | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. |
| PubMedID- 25880912 | metabolic syndrome was positively associated with fld and nafld only in males. |
| PubMedID- 24476029 | Moreover, nafld is strongly associated with metabolic syndrome in pediatric populations [23] and is considered the hepatic manifestation of this syndrome in adults [24]. |
| PubMedID- 24850609 | [effect of gene polymorphism of ppargamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity]. |
| PubMedID- 22184802 | Conclusion: from the results a hitherto widely ignored indication for nafld with or without metabolic syndrome can be derived. |
| PubMedID- 24022925 | Among all patients 234 obese children aged over 10 y were subdivided into 3 groups: nafld combined with metabolic syndrome (nafld+ms) group, nafld group and simple obesity group (control), and the above indexes were compared among 3 groups. |
| PubMedID- 24044566 | Serum adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease. |
| PubMedID- 25430922 | A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. |
| PubMedID- 24459637 | Among these patients, two underwent liver transplantation.216 the risk of nafld associated with metabolic syndrome could be as high as that in adults. |
| PubMedID- 21445622 | The pathogenesis of metabolic syndrome associated with nafld is still under debate. |
| PubMedID- 23077931 | The central role of the non alcoholic fatty liver disease in metabolic syndrome. |
| PubMedID- 24793377 | In conclusion, in contrast to bpa, bps does not appear to induce the metabolic syndrome that may lead to non-alcoholic fatty liver disease (nafld), in vitro. |
| PubMedID- 24933975 | [efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome]. |
| PubMedID- 24019613 | [4] in addition to a higher prevalence of nafld in patients with obesity, metabolic syndrome, and type 2 diabetes, it also can be induced by a variety of genetic variations. |